Literature DB >> 19200314

Lactobacillus reuteri CRL 1098 prevents side effects produced by a nutritional vitamin B deficiency.

V C Molina1, M Médici, M P Taranto, G Font de Valdez.   

Abstract

AIMS: To evaluate the efficiency of the vitamin B(12-)producing Lactobacillus reuteri CRL1098 strain in preventing the symptoms caused by a nutritional cobalamin-deficient diet in pregnant female mice and their weaned offspring. METHODS AND
RESULTS: Pregnant female mice were divided into three groups: animals fed with a B(12)-deficient diet (DD), animals fed with DD plus L. reuteri CRL1098 and animals fed with a B(12)-sufficient diet. The animals received the different feedings from the end of gestation up to weaning. At the end of the trials, they and their corresponding offspring were bled to determine haematological, immunological and histological parameters. The administration of the pseudovitamin B(12)-producing strain prevented the symptoms observed in female and weaned young animals fed with a nutritional B(12)-deficient diet.
CONCLUSIONS: Our data suggest that the pseudovitamin B(12) produced by L. reuteri CRL1098 is biologically active and effective in preventing the pathologies caused by the nutritional deficiency of B(12) both in pregnant mice and their offspring. SIGNIFICANCE AND IMPACT OF THE STUDY: The ability of L. reuteri CRL1098 to prevent a nutritional vitamin deficiency was demonstrated for the first time. The addition of a GRAS micro-organism to complement the B(12) content in deficient foods is an interesting biotechnological alternative.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200314     DOI: 10.1111/j.1365-2672.2008.04014.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  8 in total

1.  Comparison of antioxidants potential, metabolites, and nutritional profiles of Korean fermented soybean (Cheonggukjang) with Bacillus subtilis KCTC 13241.

Authors:  Muhammad Waqas Ali; Raheem Shahzad; Saqib Bilal; Bishnu Adhikari; Il-Doo Kim; Jeong-Dong Lee; In-Jung Lee; Byung Oh Kim; Dong-Hyun Shin
Journal:  J Food Sci Technol       Date:  2018-06-19       Impact factor: 2.701

Review 2.  Biochemical Features of Beneficial Microbes: Foundations for Therapeutic Microbiology.

Authors:  Melinda A Engevik; James Versalovic
Journal:  Microbiol Spectr       Date:  2017-10

Review 3.  Evolution of probiotics in aquatic world: Potential effects, the current status in Egypt and recent prospectives.

Authors:  Mai D Ibrahem
Journal:  J Adv Res       Date:  2013-12-11       Impact factor: 10.479

4.  Cobalamin production by Lactobacillus coryniformis: biochemical identification of the synthetized corrinoid and genomic analysis of the biosynthetic cluster.

Authors:  Andrea Carolina Torres; Verónica Vannini; Julieta Bonacina; Graciela Font; Lucila Saavedra; María Pía Taranto
Journal:  BMC Microbiol       Date:  2016-10-13       Impact factor: 3.605

5.  Microbial Metabolic Networks at the Mucus Layer Lead to Diet-Independent Butyrate and Vitamin B12 Production by Intestinal Symbionts.

Authors:  Clara Belzer; Loo Wee Chia; Steven Aalvink; Bhawani Chamlagain; Vieno Piironen; Jan Knol; Willem M de Vos
Journal:  mBio       Date:  2017-09-19       Impact factor: 7.867

6.  Novel Pathway for Corrinoid Compounds Production in Lactobacillus.

Authors:  Andrea Carolina Torres; Verónica Vannini; Graciela Font; Lucila Saavedra; María Pía Taranto
Journal:  Front Microbiol       Date:  2018-09-25       Impact factor: 5.640

7.  BluB/CobT2 fusion enzyme activity reveals mechanisms responsible for production of active form of vitamin B₁₂ by Propionibacterium freudenreichii.

Authors:  Paulina Deptula; Petri Kylli; Bhawani Chamlagain; Liisa Holm; Risto Kostiainen; Vieno Piironen; Kirsi Savijoki; Pekka Varmanen
Journal:  Microb Cell Fact       Date:  2015-11-23       Impact factor: 5.328

Review 8.  Role of Lactobacillus reuteri in Human Health and Diseases.

Authors:  Qinghui Mu; Vincent J Tavella; Xin M Luo
Journal:  Front Microbiol       Date:  2018-04-19       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.